| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/16/2008 | EP1911453A2 Immunemodulating oligosaccharides |
| 04/16/2008 | EP1911448A2 Lipoxins and Aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 04/16/2008 | EP1910408A2 Bifunctional protein anchors |
| 04/16/2008 | EP1910405A2 Complement c3a derived peptides and uses thereof |
| 04/16/2008 | EP1910369A1 Fused heterocycles as lck inhibitors |
| 04/16/2008 | EP1910358A2 Heterocyclic janus kinase 3 inhibitors |
| 04/16/2008 | EP1909834A2 Use of hmgb1 antagonists for the treatment of inflammatory skin conditions |
| 04/16/2008 | EP1440059B1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1169353B1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 04/16/2008 | EP0984023B9 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/16/2008 | EP0931093B1 Helicobacter pylori live vaccine |
| 04/16/2008 | EP0885244B2 Peptide immunogens for vaccination against and treatment of allergy |
| 04/16/2008 | CN101163683A 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 04/16/2008 | CN101161674A Cyclopeptide, preparation method and uses thereof |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161233A Ebstine solid oral preparation and its preparing method |
| 04/16/2008 | CN101161123A A prescription of fruit vegetables juice for dredging vascellum and improving phylactic power as well as its preparing method |
| 04/16/2008 | CN100381455C The novel antisense-oligos with better stability and antisense effect |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381436C Flavonoid compound and process for producing the same |
| 04/16/2008 | CN100381428C Quinazolone and quinazolone compound and application thereof |
| 04/16/2008 | CN100381425C 6-amino-1H-indazole and its pharmaceutical compositions as phosphodiesterase 4 inhibitors, and use thereof |
| 04/16/2008 | CN100381124C Magnesium iso-glycyrrhetate gel and its preparing method and use |
| 04/16/2008 | CN100381123C Granules of clarityne and their production method |
| 04/15/2008 | US7358415 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/15/2008 | US7358253 Indolylmaleimide derivatives |
| 04/15/2008 | US7358252 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever |
| 04/15/2008 | US7358249 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/15/2008 | US7358243 1-[9-(3-Phenyl-allyl)-3,9 diaza-bicyclo[4.2.1]non-3-yl]-propan-1-one; analgesic; great selectivity to mu receptor; analgesic; pain relief, drug dependence, alcoholism; side effect reduction |
| 04/15/2008 | US7358222 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs |
| 04/15/2008 | US7358058 Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease |
| 04/15/2008 | US7358054 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/15/2008 | US7357936 immunostimulant (3-de-O-acylated monophosphoryl lipid A) adsorbed onto metallic salt (aluminium hydroxide or aluminium phosphate); second salt with antigen which elicits immune response to polypeptide or pathogen; Hepatitis, human papilloma virus |
| 04/15/2008 | US7357925 Method for treating disorders and diseases treatable with human fibroblast interferon |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | CA2411468C Thrombopoietin mimetics |
| 04/15/2008 | CA2410303C Beta-amino acid nitrile derivatives |
| 04/15/2008 | CA2250433C Human dnase ii |
| 04/15/2008 | CA2171614C Pharmaceutical composition containing sialic acid derivatives |
| 04/15/2008 | CA2169764C Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 04/15/2008 | CA2082155C Swine pneumonia vaccine and method of preparation |
| 04/12/2008 | CA2603199A1 Shigella ipad protein and its use as a vaccine against shigella infection |
| 04/10/2008 | WO2008043031A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/10/2008 | WO2008043019A1 8-substituted 2-(benzimidazolyl) purine derivatives for immunosuppression |
| 04/10/2008 | WO2008042926A1 Cyclic modulators of chemokine receptor activity |
| 04/10/2008 | WO2008042925A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 04/10/2008 | WO2008042604A2 Immune modulators, preparations and compositions including immune modulators, tests for evaluating the activity of immune modulators and preparations and compositions including the same, and methods |
| 04/10/2008 | WO2008041236A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 04/10/2008 | WO2008040149A1 Composition and method for treating immune-mediated skin disorders |
| 04/10/2008 | WO2008040111A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | WO2008040087A1 A method of treatment and agents useful for same |
| 04/10/2008 | WO2008040057A1 Novel benzofuran potassium channel blockers and uses thereof |
| 04/10/2008 | WO2008017658A3 Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
| 04/10/2008 | WO2008003702A3 Fused bicyclic compounds interacting with the histamine h4 receptor |
| 04/10/2008 | WO2007130725A3 Use of hmgb1 for protection against ischemia reperfusion injury |
| 04/10/2008 | WO2007070385A3 Treatment of multiple sclerosis using interferon-tau |
| 04/10/2008 | WO2007048985A3 Substance for restoring normal co-expression and interaction between lox and nrage proteins |
| 04/10/2008 | US20080085939 Use Of Sphingolipids For Prevention And Treatment Of Atherosclerosis |
| 04/10/2008 | US20080085931 Inhibiting cyclin D1 production in a cell by contacting the cell with an amount of arsenic trioxide effective to inhibit cyclin D1 production therein; treatment of mantle cell lymphoma |
| 04/10/2008 | US20080085918 Fitness assay and associated methods |
| 04/10/2008 | US20080085917 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyrid-1-yl)ethyl)isoquinoline besylate salt, preparation and therapeutic use thereof |
| 04/10/2008 | US20080085909 Protein kinase C (PKC); rheumatoid arthritis, lupus, transplant rejection, asthma, inflammatory bowel disease, cancer and diabetes; for example, 2-(pyrrolidin-3-ylmethylamino)-9-(2-trifluoromethoxybenzyl)-7,8-dihydro-9H-purin-8-one |
| 04/10/2008 | US20080085898 And 8-substituted 2-(imidazolo[4,5-c]pyridinyl)purines; Janus kinase 3 inhibitors; autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection |
| 04/10/2008 | US20080085896 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 04/10/2008 | US20080085891 Asthma and allergic inflammation modulators |
| 04/10/2008 | US20080085883 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
| 04/10/2008 | US20080085868 Non-infectious nucleic acid construct encoding a recombinant antibody to that agent; injection of a nucleic acid construct, in the form of a plasmid, encoding a virus-neutralising single chain antibody fragment mediates in vivo expression of antibodies; protecting an animal against exposure to a virus |
| 04/10/2008 | US20080085861 Gas1 polypeptides |
| 04/10/2008 | US20080085859 Drug Promoting Ceramide Transport, Base Sequence for Producing the Drug, Method of Measuring Activity of Promoting Ceramide Release and Method of Measuring Activity of Promoting Intermembrane Ceramide Transfer |
| 04/10/2008 | US20080085858 Pharmaceutical Composition |
| 04/10/2008 | US20080085328 Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof |
| 04/10/2008 | US20080085311 Antihistamine-decongestant combinations |
| 04/10/2008 | US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids |
| 04/10/2008 | CA2665351A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | CA2665141A1 Composition comprising crustacean gastrolith components and its use |
| 04/10/2008 | CA2664621A1 Pyrazine-2-carboxamide derivatives |
| 04/10/2008 | CA2564154A1 Immunocan |
| 04/09/2008 | EP1908837A2 Human receptor proteins, related reagents and methods |
| 04/09/2008 | EP1908823A1 Component of bromelain |
| 04/09/2008 | EP1908781A2 Modulation of immune response and methods based thereon |
| 04/09/2008 | EP1908780A1 Novel chimeric proteins and methods for using the same |
| 04/09/2008 | EP1908479A2 Anti-p53 Antibodies |
| 04/09/2008 | EP1907407A1 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation |
| 04/09/2008 | EP1906964A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
| 04/09/2008 | EP1675605B1 Pharmaceutical composition which can be used, for example, as an antiviral or antibacterial agent and to stimulate immune defences |
| 04/09/2008 | EP1660118B1 Method for identification of regulatory tr1 lymphocytes by the presence and overexpression of specific molecules and application thereof |
| 04/09/2008 | EP1450796B1 Benzothiazole derivatives |